PRANA EXPANDS COLLABORATION WITH UNIVERSITY OF MELBOURNE.Prana Biotechnology Limited (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :PRAN PRAN Airman, Parachute Rigger Striker (Naval Rating) ), Melbourne, Australia, has announced a substantial expansion to its existing University of Melbourne
In 2006, Times Higher Education Supplement ranked the University of Melbourne 22nd in the world. Because of the drop in ranking, University of Melbourne is currently behind four Asian universities - Beijing University, agreement to lengthen the collaboration by two years to 2006 while intensifying research into new drug candidates. Executive Chairman Geoffrey Kempler said, "Prana continues to enjoy a highly productive relationship with the University of Melbourne. This extension effectively adds a minimum of two years to our association and shows the continuing commitment to our drug development objectives." The eminent neuroscience researcher Professor Colin Masters, Professor of Pathology at the University of Melbourne and a Director of Prana, will continue to oversee this research team. Professor Masters' laboratory has been a global leader in Alzheimer's disease research for over 20 years. Prana Biotechnology will own all results of the research program. The original agreement between Prana Biotechnology and the University of Melbourne was signed in May 1999 with the objective of furthering Prana's research program into the underlying mechanisms of Alzheimer's disease and related neurodegenerative disorders. Arising from this research to date has been the development of Prana's MPAC MPAC Muslim Public Affairs Council MPAC Municipal Property Assessment Corporation MPAC Muslim Public Affairs Committee MPAC Missouri Precision Agriculture Center MPAC Member Political Action Conference MPAC Medicare Payment Advisory Commission platform technology and the identification of other therapeutic approaches with exciting promise for the treatment of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. About Prana Biotechnology Limited Based in Australia, incorporated in 1997 and listed on the Australian Stock Exchange Australian Stock Exchange (ASX) Australia's major securities market, formed when the six state stock exchanges (Adelaide, Brisbane, Hobart, Melbourne, Perth, and Sydney stock exchanges) were merged in 1987. in March 2000, Prana Biotechnology (NASDAQ:PRAN) was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Its mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world at Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. and the University of Melbourne. For more information, visit http://www.pranabio.com or call 212/983-1702 ext. 209. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion